Previous studies have demonstrated SIRT5’s tumor-suppressive roles in PDAC [14] and renal cell carcinoma [20], while others have reported an oncogenic function in breast cancers [21,22]. The gene discussed is SIRT5; the disease is hereditary clear cell renal cell carcinoma.